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ABSTRACT
Introduction: Aerobic gymnastics is a sport that has 
consistently grown over the previous decades, and 
its practice demands its athletes to perform complex 
and high-intensity movements. Objective: Study 
was to analyze whether ginger supplementation 
had an ergogenic eff ect on the anaerobic power 
of limbs (PAMI) in aerobic gymnastic athletes. 
Methods: A randomized double-blind placebo-
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controlled trial was conducted with nine athletes 
(23.11 + 4.14 years, 1.63 + 0.09 m, 60.51 + 7.38 
kg) from the Brazilian National Team of Aerobic 
Gymnastics. After ingesting 400 mg of Zingiber 
offi  cinale or placebo for seven days, the subjects 
underwent an anaerobic power test (RAST). Peak 
Velocity and Peak power (m/s and W), average and 
minimum power (W) and fatigue index (W/s and 
%) data were obtained from the RAST. Results: 
After verifying the no normality of the sample, the 
Mann-Whitney was applied, but no signifi cant 
diff erences were found in the peak velocity of the 
ginger supplementation (6.28 ± 0.41 m/s; 445.28 ± 
117.15 W) compared to placebo (6.22 ± 0.45 m/s; 
425.95 ± 130.39 W). Conclusions: It is concluded 
that ingesting 400 mg of Z. offi  cinale does not have 
an ergogenic eff ect on the anaerobic power of the 
lower limbs of aerobic gymnastic athletes.
Keywords: Ergogenic Eff ect; Gymnastics 
Aerobics; Phytotherapeutic; Strength.
RESUMO
Introdução: a ginástica aeróbica é um esporte 
que tem crescido consistentemente nas últimas 
décadas, e sua prática exige que seus atletas 
realizem movimentos complexos e de alta 
intensidade. Objetivo: analisar se a suplementação 
com gengibre tem efeito ergogênico no poder 
anaeróbico dos membros (PAMI) em atletas de 
ginástica aeróbica. Métodos: foi realizado um 
estudo randomizado, duplo-cego, controlado por 
placebo, com nove atletas (23,11 + 4,14 anos, 1,63 
+ 0,09 m, 60,51 + 7,38 kg) da Seleção Brasileira 
de Ginástica Aeróbica. Após a ingestão de 400 
mg de Zingiber offi  cinale ou placebo por sete 
dias, os indivíduos foram submetidos a um teste 
de potência anaeróbica (RAST). Os dados de 
Velocidade de pico e Potência de pico (m/s e W), 
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potência média e mínima (W) e índice de fadiga 
(W/s e %) foram obtidos no RAST. Resultados: 
Após verifi car a não normalidade da amostra, 
foi aplicado o Mann-Whitney, mas não foram 
encontradas diferenças signifi cativas na velocidade 
de pico da suplementação de gengibre (6,28 ± 
0,41 m / s; 445,28 ± 117,15 W) em comparação 
ao placebo (6,22 ± 0,45 m / s; 425,95 ± 130,39 W). 
Conclusões: conclui-se que a ingestão de 400 
mg de Z. offi  cinale não exerce efeito ergogênico 
no poder anaeróbico dos membros inferiores de 
atletas de ginástica aeróbica.
Palavras-chave: Efeito Ergogênico; Ginástica 
Aeróbica; Fitoterapêutico; Força.
INTRODUCTION
Aerobic gymnastics is a non-Olympic sport 
that has consistently grown over the previous 
decades, and its practice demands its athletes to 
perform complex and high-intensity movements 
following musical patterns1. These movements are 
related to aerobic and anaerobic power, strength 
and fl exibility2.
High-intensity training is a type of exercise 
that induces infl ammation, which promotes 
tissue repair and remodeling3, this is associated 
with increased damage-associated molecular 
patterns (DAMPs) and the innate release of pro-
infl ammatory cytokines, such as TNF -α and IL-6, 
and enzymes such as cyclooxygenase (COX) -1 and 
2, substances that promote late muscle pain and 
decrease performance3,4. In response to exercise, 
the synthesis of infl ammatory cytokines, such as 
TNF-α, is regulated by diff erent signaling pathways, 
including the COX-prostaglandin cascade5. Studies 
have analyzed the use of drugs by athletes in order 
to promote the inhibition of these infl ammatory 
processes6,7,8. Through their inhibitory eff ect on 
COX-1 and COX-2 enzymes, nonsteroideal anti-
infl ammatory drugs (NSAIDs) have been shown to 
reduce infl ammatory responses that occur in the 
acute recovery phase of exercise9. However, the use 
of NSAIDs by athletes aiming at an ergogenic eff ect 
leads to a series of acute and chronic concerns, 
since these drugs can cause gastrointestinal 
pain and hemorrhage, hepatitis and anaphylactic 
reactions10. This is because NSAIDs have an eff ect 
on two COX isoenzymes; the COX-2 isoenzyme is 
associated with edema and pain perception11, while 
the COX-1 isoenzyme plays an important role in the 
synthesis of prostaglandins through a protective 
function of the gastric mucosa11.
An alternative to NSAIDs is the use of 
phytotherapeutic compounds such as ginger12. 
Studies evaluating the eff ect of ginger in vitro, humans 
and rodents, show that it aff ects the isoenzyme 
COX-213, which has an anti-infl ammatory eff ect 
mediated by the inhibition of macrophages and 
neutrophils and negatively controls the migration 
of neutrophils and leukocytes, such as evidenced 
by the dose-dependent decrease in chemokines 
and pro-infl ammatory cytokines, such as TNF-α14 
and C-reactive protein15 and by the replacement 
of the total antioxidant capacity16. This, in turn, has 
a direct eff ect on COX-2 inhibition17, 18, 19. Unlike 
NSAIDS, the specifi c action of ginger on COX-
213 would increase the synthesis of leukotrienes 
and prostaglandins, thereby promoting gastric 
function20. Because of all of these functions, ginger 
is used in treating infl ammatory diseases, such as 
arthritis and rheumatism, diseases of the nervous 
system, gingivitis and diabetes21.
Diff erent investigations have analyzed the 
eff ect of ginger supplementation on subjects who 
underwent training programs with the objective of 
proving a possible ergogenic eff ect. Thus, diff erent 
studies corroborate the eff ect of supplementation 
in individuals with low level of physical fi tness, 
such as obese subjects undergoing high intensity 
interval training (HIIT) programs, which showed a 
decrease in interleukin 6 and increased aerobic 
capacity22, or strength training that showed the 
decrease in the percentage of body fat, body 
fat mass, total cholesterol mass and insulin 
resistance23. On the other hand, research carried 
out in populations with a moderate level of training 
analyzed the eff ects of ginger supplementation 
on variables such as decreased potency levels, 
pain perception, late-onset muscle pain (DOMS) 
and / or damage-marking enzymes muscular. 
after a standard resistance training session18,24 or 
a long distance run10, and show a positive eff ect 
accelerating recovery. Because no research has 
focused on the eff ect of ginger supplementation 
on highly trained athletes or on eff orts with a high 
glycolytic component, this study aimed to analyze 
whether ginger supplementation had an ergogenic 
eff ect on the anaerobic power of lower limbs (APLL) 
performance in aerobic gymnastics athletes.
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METHODS
A randomized double-blind placebo-
controlled trial was conducted with nine athletes 
from the Brazilian Aerobic Gymnastics team: 
four males and fi ve females. The project was 
approved by the Ethics Committee of the Federal 
University of Lavras under CAAE protocol number: 
67813817.1.0000.5148. Table 1 presents the 
physical characteristics of the subjects.
The study was divided into three parts. The 
fi rst part was developed in the Laboratory of Sports 
Nutrition, located in the Department of Nutrition 
(DNU), and the other two parts were developed 
in the Laboratory of Human Movement Studies 
(LEMOH), located in the Department of Physical 
Education (DEF).
The athletes were evaluated in a placebo-
controlled crossover trial with a seven-day washout 
period25. The fi rst part of the study consisted of an 
anthropometric evaluation and signing of the TCLE. 
Next, there was a 24 h interval before beginning 
the second part of the study supplementation 
with either ginger or placebo for seven days. At 
the end of the seventh day PAMI was evaluated 
through the running anaerobic sprint test (RAST) 
following the protocol used by26. After a washout 
period of seven days, the groups were crossed, 
and supplementation immediately began, lasting 
for seven days. After the last day, PAMI analysis 
was again performed (Image 1).
For seven days, the athletes ingested a 
400 mg (0.35% total gingerols) capsule of ginger 
extract (Zingiber offi  cinale) or placebo (400 mg 
starch) taken daily in the morning with water. 
The capsules were made in a pharmacy that was 
accredited by the Regional Pharmacy Council 
of Minas Gerais/MG. Gelatin size 1 capsules in 
red and white colors were used for both ginger 
and the placebo, following parameters stipulated 
by27. On the seventh day of supplementation, 
the athletes performed the physical tests. The 
athletes were instructed to maintain their usual 
dietary intake during the study period. They were 
also instructed to eat the same meal on the days 
of the physical tests.
Table 1. Physical characteristics of the study participants (n = 9)
Legends:  M: Average; S: Standard deviation; %: percentage; Kg/m²: kilogram per square meter; m: meter; Kg: kilogram.
Image 1. Experimental design
Legends: TCLE: Informed consent form; RAST: Running anaerobic sprint test
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To characterize the sample, height and 
body mass data were collected from a scale with 
a stadiometer (110 FF, Welmy®, Santa Bárbara 
d’Oeste, Brazil). The percent body fat was 
determined using the multifrequency octapolar 
InBody apparatus (Biospace, model 230 - InBody 
Body Composition Analyzers, Korea), the sample 
was instructed to fast for at least 4 hours, do not 
perform intense physical activity in the 24 hours 
prior to the test, urinate at least 30 minutes before, 
do not consume alcoholic beverages in the previous 
48 hours and do not use diuretics for 7 days before. 
Prior to RAST assessment protocol initiation, 
a standard warm-up was performed in which 
the volunteers performed 20-s sustained limb 
stretching and subsequently completed a light 
3-min running slowly after an interval of 1 min. The 
RAST consisted of six 35 m sprints, interspersed 
by a passive recovery period of 10 s. The time was 
recorded for each eff ort (Timex®, model 85103). 
The absolute power (Pabs), in Watts (W), was 
determined in each run by measuring the time (t), 
distance (D) and body mass (BM) of the individual 
(Pabs (W) = (BMxD2)/t3). RAST variables were 
determined, including the peak velocity (PV), peak 
power (PP), mean power (MP) and minimum power 
(MinP), and are represented both in units relative 
to body mass (REL) and in absolute values (ABS). 
The fatigue index (FI) (FI (%) = (PP – MinP) x 100)/
PP) was also calculated. In addition, the maximum 
velocity (VMAX) and the mean velocity (VMEAN) 
were determined through the relationship between 
distance and eff ort time28.
All variables are presented as the mean 
(M) and standard deviation (SD), along with 
the coeffi  cient of variation (CV) expressed as a 
percentage. The Shapiro-Wilk test was applied to 
verify the normality of the data. As the assumptions 
of normality do not were met, the Mann- Whitney 
test was used to compare the two stages of the 
study (ginger and placebo), and for analyzing 
variation among the data, the Δ test was used. 
The eff ect size (ES) was calculated according to 
Cohen’s d. The level of signifi cance (α) was set at 
5%.  It was also used Magnitud-based inferences. 
Statistical processing was performed with the 
SPSS software (21.0, IBM, Armonk, USA).
RESULTS
Image 2 shows that there were no signifi cant 
diff erences when comparing PV (m/s) after ginger 
supplementation relative to placebo (6.28 ± 0.41 
m/s vs. 6.22 ± 0.45 m/s, p = 0.645, ES = 0.006).
Image 2. Levels of PV (m/s) obtained after ginger 
supplementation vs. placebo.
Legends: Peak Velocity; m/s: meters per second
Table 2. Comparison of velocity, power levels and fatigue index after supplementation with ginger vs. placebo.
Legends: M: Average; S: Standard deviation; PV: Peak Velocity; PP: Peak Power; AP: Average Power; MP: Minimal 
Power; FI: Fatigue Index; ∆: Delta; ES: Eff ect Size.
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Likewise, no signifi cant diff erences were 
observed between the two experimental conditions 
in the following variables: PV, PP, MP, MinP (W) or 
FI (Table 2).
DISCUSSION
Our fi ndings showed that there was no 
signifi cant diff erence when comparing the placebo 
and ginger groups. When analyzing the APLL, 
there was no signifi cant diff erence between the 
ginger and placebo groups in terms of the PV and 
PP (m/s and Watts), mean (Watts) and minimum 
(Watts) power variables.
The test used in the present study included 
a high-intensity race, an exercise modality 
that includes eccentric high-intensity actions, 
which has been shown to generate a greater 
infl ammatory response and muscle damage than 
other modalities such as the cycloergometer29. 
After this type of exercise, both infl ammation and 
pain perception are considered good indicators 
of muscle damage30. Two previous studies 
evaluated the eff ect of ginger supplementation 
on running10, 27. In the fi rst investigation, aimed to 
demonstrate the eff ect of supplementation with 
2.2 g/day of ginger compared to placebo in a 
sample of subjects trained in a crossover study 
on DOMS, as well as on loss of performance 
in a countermovement jump (CMJ) after a 20-
22-mile race at training pace10. The decrease 
in CMJ jump height shortly after fi nishing the 
exercise compared to the previous values was 
considered a good indicator of muscle fatigue31, 
3(ii2. In that study, the researchers found that ginger 
supplementation had a positive eff ect on DOMS 
reduction and had no eff ect on muscle fatigue, 
since it did not attenuate the loss of performance 
in CMJ. Subsequently, the same group of 
researchers27 also did not observe any eff ect of 
ginger supplementation (1.425 g/day) in runners 
in muscle fatigue (analyzed by the decrease in 
performance in CMJ) after a 40-min incline test; 
however, it was eff ective in reducing DOMS.
The results of the previous studies10, 27 
coincide with the fi ndings which showed that 
supplementation with 2 g/day ginger had a positive 
eff ect on pain reduction according to a visual analog 
scale (VAS) compared placebo after performing 
an eccentric training session consisting of three 
sets of six repetitions with a duration of 3 s and a 
load of 120% of one-repetition maximum (1RM)24. 
However, in that study, no eff ect of supplementation 
on the recovery of maximal isometric power levels 
of the arms was observed, both at the end of the 
training and at 72 h after completion.
The demonstrated ineffi  ciency of previous 
investigations of ginger supplementation in 
reducing neuromuscular performance loss after 
an exercise protocol10, 24, 27are in agreement with 
the absence of improvement found in our study 
after supplementation. These results may occur 
due to the lack of eff ects of ginger in preventing 
muscle catabolism during physical exercise, 
which may explain results that showed no eff ect 
of supplementation with 4 g/day of ginger for 
fi ve days to minimize increased muscle damage 
marker enzymes such as creatine kinase (CK) and 
lactate dehydrogenase (LDH) after an eccentric 
training session for the upper limbs18. DOMS is 
related to muscle damage3, and supplementation 
with ginger may have an eff ect on DOMS and pain 
perception in the absence of diff erent responses 
in muscle structures. Thus, the eff ect of ginger 
supplementation on the COX-2 isoenzyme, 
infl ammatory cytokines and leukotriene synthesis 
could block the increase in mechanical muscle 
tissue hypersensitivity by reducing the activation of 
type III and IV aff erent nerves due to bradykinin and 
sensitization of aff erent fi bers by prostaglandins 
and infl ammatory cytokines interleukin 1 and 6 (IL-
1 and IL-6)24. Moreover, diff erent components of 
ginger act as agonists of transient receptor potential 
cation channel subfamily V member 1 (TRPV1) 
receptors16, which participate in nociception and 
pain perception16. Thus, chronic supplementation 
could reduce the sensitivity of nociceptive 
receptors to mechanical and chemical stimuli14, 
possibly through the depletion of substance p19.
Although ginger supplementation can have 
positive eff ects in reducing DOMS, reducing the 
activation of type II and IV24 aff erent nerves and 
their agonist action on TRPV124 receptors, these 
eff ects are not able to have a positive eff ect on 
the performance of a PAMI test, as found in the 
results of the present investigation and recovery 
from exercise10, 24, 27. Other studies have not found 
an ergogenic eff ect of ginger supplementation in 
combination with a long-term training program 
(10 weeks) compared to placebo training on the 
variables of body composition and fi tness22, 23.
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CONCLUSIONS
Long-term ginger supplementation is safe; 
however, the present study demonstrated that 
ginger has no eff ect on the anaerobic power of the 
lower limbs or the fatigue index in aerobic gymnastic 
athletes. The data found with this population 
highlights that supplementation with ginger cannot 
be considered an ergogenic nutritional aid in sport.
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